Canadian dermatologist Dr. Ronald B. Vender discusses topical methotrexate, systemic medications in pediatric patients, and depression.

Canadian dermatologist Dr. Ronald B. Vender discusses whether or not vitamin D has any impact on psoriasis severity, sex differences in psoriatic inflammation itch, and risk of psychiatric disorders associated with acitretin.

Canadian dermatologist Dr. Ronald B. Vender discusses psoriatic skin lesions, methotrexate and nonmelanoma skin cancer, and face-to-face time between patients and physicians.

Canadian dermatologist Dr. Ronald B. Vender discusses comorbid obesity, the effect of smoking on psoriasis, and apremilast in real world studies.

Canadian dermatologist Dr. Ronald B. Vender discusses mental health comorbidities of psoriasis, restless legs syndrome, and shared decision-making with dermatologists.

Canadian dermatologist Dr. Ronald B. Vender discusses PASI thresholds, migraines, and the importance of topical treatment application feel to a patient.

Canadian dermatologist Dr. Ronald B. Vender talks about paradoxical eczema in psoriasis patients on biologics, real-world blood screening, and patient satisfaction for brodalumab.

Canadian dermatologist Dr. Ronald B. Vender talks about acitretin-methotrexate therapy in pediatric patients, psoriasis flares from systemic steroids, and adalimumab with methotrexate versus adalimumab mono therapy.